Altimmune closed a $75M direct offering to fund Phase 3 pemvidutide trials for MASH, leveraging recent positive Phase 2b data and FDA Breakthrough Therapy status. Pemvidutide’s dual GLP-1/glucagon ...
Company Expects to Report Topline Data from OPUS-3 Trial and OPUS-2 Phase 3 Trial Evaluating Concomitant Administration of VAX-31 and a Seasonal Influenza Vaccine in First Half of 2027 OPUS-1, VAX-31 ...
Roche has shared the numbers behind its phase 3 win in primary progressive multiple sclerosis (PPMS), linking its BTK inhibitor to a 12% reduction in the risk of disability progression compared to ...
Patients in a phase 2b trial kept losing weight after switching to monthly dosing of Pfizer’s GLP-1 receptor agonist, providing early validation of the drugmaker’s $10 billion bet on Metsera. The ...
This marks the completion of enrollment of all male Phase 3 studies of VDPHL01 in pattern hair loss, with approximately 1,000 male patients enrolled across studies Topline data from initial '302' ...
Getting your Trinity Audio player ready... Nuggets guard Jamal Murray has agreed to compete in the NBA 3-point contest at All-Star weekend next Saturday, the league announced. Murray will already be ...
India’s refiners rely on discounted Russian heavy crude that is difficult and costly to replace. Switching to U.S. oil would raise costs and strain refinery operations. Washington’s tougher stance ...
OCEANIC-STROKE shows asundexian cuts ischemic stroke recurrence by 26% in patients taking standard antiplatelet therapy, with no major bleeding increase. Asundexian is a direct oral inhibitor of FXIa ...
Patients with advanced lung cancer had better survival outcomes when they received immunochemotherapy earlier in the day, a randomized trial showed. Morning circulating CD8+ T cells increased in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results